Found 115 results for michael gantier

  • Cancer drug investigated as anti-inflammatory for lethal conditions including COVID-19

    An existing cancer drug could potentially modify a severe hyper-inflammatory ‘storm’ associated with some conditions, which may include the COVID-19 virus, according to Hudson Institute researchers. Dr Michael Gantier The……  Read more

    Dr Michael Gantier from the Nucleic Acids and Innate Immunity Research Group at Hudson Institute

  • US FDA approval sought for clinical trial – potential COVID-19 treatment

    …that it could act as an anti-inflammatory. Dr Michael Gantier Announced earlier this month, researchers found in laboratory tests that the active ingredient in the medication, idronoxil, could block the……  Read more

    Dr Michael Gantier from the Nucleic Acids and Innate Immunity Research Group at Hudson Institute

  • Making more effective and efficient RNA therapeutics

    …deal. Associate Professor Michael Gantier The licensing agreement has been signed between Hudson Institute and Australian clinical-stage drug development company Noxopharm Limited, through its wholly-owned subsidiary, Pharmorage Pty Ltd. The……  Read more

    Associate Professor Michael Gantier, developing RNA therapeutics subject to a new licensing deal, Noxopharm Limited.

  • Victorian government funding boost for new anti-inflammatory treatments

    …Michael Gantier The Victorian Government has granted $1.45 million to Hudson Institute of Medical Research, working with its collaborator Pharmorage Pty Ltd, to fund the joint development program of novel anti-inflammatory……  Read more

    Associate Professor Michael Gantier's groundbreaking research into inflammation has attracted funding support from the Victorian government to assist with new anti-inflammatory treatments.

  • Firefighters Charity Fund supports BRCA1 research

    …the Nucleic Acids and Innate Immunity Laboratory run by Associate Professor Michael Gantier and the Medical Genomics Facility run by Dr Trevor Wilson PhD, where they were able to see……  Read more

    Firefighters Charity Fund support BRCA1 gene sequencing at Hudson Institute of Medical Research.

  • Hyper-acute inflammation in COVID-19

    …by Dr Michael Gantier, is looking for treatments to help prevent chronic and hyper-acute inflammation. Nucleic acids are the root cause of toxic inflammation in chronic diseases like lupus, or……  Read more

    Dr Michael Gantier from the Nucleic Acids and Innate Immunity Research Group at Hudson Institute